Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.41M | 28.39M | 28.29M | 27.63M | 27.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 126.17M | 126.63M | 127.62M | 128.44M | 128.09M |
| Operating Income | -126.17M | -126.63M | -127.62M | -128.44M | -128.09M |
| Income Before Tax | -118.64M | -117.32M | -117.12M | -117.88M | -137.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -118.64 | -117.32 | -117.12 | -117.88 | -137.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -118.64M | -117.32M | -117.12M | -117.88M | -137.29M |
| EBIT | -126.17M | -126.63M | -127.62M | -128.44M | -128.09M |
| EBITDA | -119.62M | -120.13M | -121.15M | -121.91M | -121.50M |
| EPS Basic | -1.30 | -1.29 | -1.34 | -1.70 | -2.53 |
| Normalized Basic EPS | -0.82 | -0.81 | -0.83 | -1.07 | -1.30 |
| EPS Diluted | -1.30 | -1.29 | -1.34 | -1.70 | -2.53 |
| Normalized Diluted EPS | -0.82 | -0.81 | -0.83 | -1.07 | -1.30 |
| Average Basic Shares Outstanding | 363.85M | 363.40M | 351.40M | 303.59M | 255.72M |
| Average Diluted Shares Outstanding | 363.85M | 363.40M | 351.40M | 303.59M | 255.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |